跳至主要内容
临床试验/NCT02026219
NCT02026219已完成4 期

Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in Acute Coronary Syndrome Patients: The Index of MIcrocirculatory Resistance After PCI in STEMI Patients (TIME Study)

Inha University Hospital1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
76
试验地点
1
主要终点
Index of microcirculatory resistance (IMR) measured after successful coronary intervention

研究概览

简要总结

Ticagrelor is a non-thienophyridine, direct P2Y12 blocker that is more potent than clopidogrel and is associated with less interindividual variability. In the PLATO trial, it was found to be superior to clopidogrel with respect to cardiovascular outcomes and total mortality without increasing the risk of bleedings.

More potent and reversible receptor bindings are possible explanation for the superior outcomes. Beside the potent effect on inhibition of antiplatelet function, ticagrelor has previously been demonstrated to increase adenosine levels by inhibiting adenosine re-uptake in tissue level and can induce adenosine triphosphate (ATP) release from human red cells, which both stimulate vasodilation of in red blood cells.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and Females
  • between the ages of 18 and 75 years
  • STEMI patients treated with percutaneous coronary intervention
  • Able to provide informed consent

排除标准

  • History of stroke or transient ischemic attack
  • Platelet count < 100 000/μL
  • Known Bleeding Diathesis
  • Hematocrit <30% or >52%
  • Severe Liver Dysfunction
  • Renal Insufficiency (Creatinine Clearance < 30ml/min)
  • Pregnant females
  • Cardiogenic shock or symptomatic hypotension or sitting SBP < 95 mmHg

研究组 & 干预措施

Clopidogrel

Experimental

Clopidogrel 600mg loading

干预措施: Clopidogrel (Drug)

Ticagrelor

Experimental

Ticagrelor 180mg loading

干预措施: Ticagrelor (Drug)

结局指标

主要结局

Index of microcirculatory resistance (IMR) measured after successful coronary intervention

时间窗: IMR will be immediately assessed after successful PCI patients within 48hr from admission

次要结局

  • wall motion score index on three month later TTE from index PCI(TTE will be assessed in all enrolled patients 3 month later from index PCI)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparison of Clopidogrel and Ticagrelor on... | 临床试验